Sort
48,018 grants matching “immunotherapy”
Development of a New Strategy to Treat Locally Advanced Pancreatic Cancer
$400,246Scott Andrew Gerber · University Of Rochester · R01 · FY2021 · CA
Development of a New Strategy to Treat Locally Advanced Pancreatic Cancer
$400,246Scott Andrew Gerber · University Of Rochester · R01 · FY2020 · CA
Diabetes Mellitus Periodontal Dis Children &Adolescents
$400,240Columbia University Health Sciences · R01 · FY2003 · DE
Hes1-loss promotes dysregulation of epithelial homeostasis and inflammation in a serrated adenocarcinoma model
$400,205Lan Zhou · Case Western Reserve University · R01 · FY2019 · CA
Developing a Translation Pipeline for VHL Mutant Malignancies
$400,168David McDermott · Beth Israel Deaconess Medical Center · U01 · FY2022 · CA
Pharmacologic Enhancement of Viral Oncolysis
$400,162E. Antonio Chiocca · Massachusetts General Hospital · P01 · FY2010 · CA
Targeting evolving therapy resistance
$400,151Yael P Mosse · Children'S Hosp Of Philadelphia · P01 · FY2024 · CA
Community Clinical Oncology Program
$400,119Northshore Univ Healthsystem Res Inst · U10 · FY2004 · CA
Project 2: Analyses of the human GBM microenvironment form clinical trial specimens treated with the oncolytic HSV, rQNestin34v.2
$400,081E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2023 · CA
Macrophage polarization in glioma microenvironment
$400,079Yi Fan · University Of Pennsylvania · R01 · FY2018 · NS
Project 1:Therapeutically improving HNSCC antigenicity through epigenetic reprogramming
$400,078Sara Isabel Pai · Massachusetts General Hospital · P01 · FY2022 · CA
Project 2: Redirecting pre-existing anti-viral immunity to HNSCCs with APECs
$400,074Thorsten Roman Mempel · Massachusetts General Hospital · P01 · FY2022 · CA
Targeting metastatic tumors with engineered cellular therapies
$400,053Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2025 · CA
A Novel Symbiotic Approach For Targeted Ovarian Cancer Therapy
$400,048Jogender Tushir-Singh · University Of Virginia · R01 · FY2019 · CA
Inhibitory Pathways Underlying Viral Persistance in vivo
$400,044Elina I Zuniga · University Of California, San Diego · R01 · FY2010 · AI
Role of Myeloid And CD4+ T Immune Cells in Post-Traumatic Plasticity
$400,029Jeanne T Paz · J. David Gladstone Institutes · R01 · FY2024 · NS
Enzymology of Mismatch Repair in Yeast
$400,001Richard D Kolodner · Ludwig Institute For Cancer Res Ltd · R01 · FY2020 · GM
IL-27 and Treg cells
$400,000Christopher A Hunter · University Of Pennsylvania · R01 · FY2014 · AI
Enzymology of Mismatch Repair in Yeast
$400,000Richard D Kolodner · Ludwig Institute For Cancer Res Ltd · R01 · FY2021 · GM
Regulation and function of nonlymphoid organ CD103 dendritic cells
$400,000Stephanie S Watowich · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · AI
Point-of-care autologous CAR-T cell manufacturing
$400,000Yu-Tsueng Liu · Aerocytek, Inc. · R43 · FY2025 · CA
The Immunosuppressive Function of Checkpoint Kinase 2 in Gliomas
$400,000Crismita Clement Dmello · Northwestern University At Chicago · R01 · FY2025 · NS
IL-27 and Treg cells
$400,000Christopher A Hunter · University Of Pennsylvania · R01 · FY2017 · AI
P5 - P-53-Based Vaccine for Small Cell Lung Cancer
$400,000Dmitry Isaac Gabrilovich · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2012 · CA
CANCER CENTER SUPPORT GRANT
$400,000University Of Colorado Denver · P30 · FY2001 · CA